Company Filing History:
Years Active: 2020-2025
Title: Elise Ishida: Innovator in HIV-1 Research
Introduction
Elise Ishida is a prominent inventor based in Chevy Chase, MD (US). She has made significant contributions to the field of biomedical research, particularly in the development of neutralizing antibodies for HIV-1.
Latest Patents
Elise Ishida holds two patents related to her groundbreaking work. Her latest patents focus on neutralizing antibodies to GP120, which specifically bind to gp120 and neutralize HIV-1. These patents disclose antibodies and antigen binding fragments, as well as nucleic acids encoding these antibodies, vectors, and host cells. Additionally, methods for detecting HIV-1 using these antibodies are outlined. The patents also describe the use of these antibodies, antigen binding fragments, nucleic acids, and vectors to prevent and/or treat HIV-1 infections.
Career Highlights
Elise Ishida is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to focus on innovative research that addresses critical health challenges.
Collaborations
Some of her notable coworkers include Mark Connors and Jinghe Huang, who contribute to the collaborative environment that fosters innovation and research excellence.
Conclusion
Elise Ishida's work in developing neutralizing antibodies for HIV-1 represents a significant advancement in the fight against this virus. Her contributions continue to impact the field of biomedical research and offer hope for effective treatments.